Why culture remains the gold standard: about two cases of Staphylococcus aureus bloodstream infections Authors: Sylvain Meyer, Thomas Lafon, Olivier Barraud Published: 2026 LETTER Genomics is now widely used as a first-line routine test to predict bacterial identification and/or antimicrobial resistance. Genomics has become the reference for many bacteriological analyses, overpassing conventional microbiology and phenotypic tests because of its time-saving advantages and greater sensitivity. Nevertheless, PCR can, in rare cases, fail to amplify the targeted gene, especially if modifications in the target sequence, such as mutations, insertions, or deletions are present. Here, we present two clinical cases of Staphylococcus aureus bloodstream infections where amplification of the protein A encoding gene (spa) failed to identify S. aureus and amplification of the methicillin resistance gene (mecA) failed to detect methicillin susceptibility. The first patient was admitted to the emergency unit of Limoges University Hospital in August 2023 with septic shock. Blood culture became positive in 8 hours with gram-positive cocci. PCR using the XpertMRSA/SA Blood Culture Kit (Cepheid) was performed and showed absence of amplification for the spa and mecA genes. Identification performed from culture using the MALDI Biotyper System (Brucker) confirmed the presence of S. aureus (LIM207). In front of this discrepancy, whole genome sequencing of LIM207 was performed using the Ion GeneStudio platform (Thermo Fisher Scientific), as previously described (1). This ST121 isolate was found to have a deletion of 48 nucleic acids in the spa gene (Fig. 1A). The exact region amplified by the PCR kit not being known, it is expected that the primers or probe of this qPCR target this deleted region. The patient died 1 day after admission despite receiving adapted antibiotic therapy from the time of admission. Comparison of spa gene (A) and mecA gene (B) of sequenced S. aureus isolates against reference sequence NZ_CP027476.1 using Geneious Prime software. The stop codon is highlighted in red. The second patient was admitted to the same emergency unit with a suspicion of dermohypodermitis without septic shock. Blood cultures became positive in 9 hours with gram-positive cocci. The same XpertMRSA/SA Blood Culture Kit showed both spa and mecA amplifications in favor of methicillin-resistant S. aureus. Bacterial culture confirmed the S. aureus identification, but antimicrobial susceptibility testing (AST) showed methicillin-susceptible S. aureus (MSSA). Confirmation of methicillin susceptibility was performed using three different tests: cefoxitin disk diameter >22 mm, oxacillin MIC ≤0.25 mg/L, negative cefoxitin test on the Vitek2 AST-P631 card (bioMérieux), and negative PLP2a immunochromatography using the ClearviewPBP2a SA Culture Colony Test (Abbott). WGS showed this ST5 S. aureus (LIM208) had an SCCmec type IV with a deletion of 16 nucleic acids in the mecA gene at position 309, leading to an early stop codon of this PLP2A protein at position 121 (Fig. 1B). Because of this discrepancy, the patient was first treated with linezolid and gentamicin, with a switch to cefazolin after MSSA confirmation. The patient died a couple of weeks later due to a massive S. aureus endocarditis. In conclusion, these two cases highlight the limit of PCR and the importance of systematic conventional culture and AST to confirm diagnosis. Deletion of part of the genome has been previously reported in S. aureus (2), but small deletions inside the spa or mecA genes are very uncommon, with a potential impact on PCR results or gene expression (3). These two S. aureus isolates are atypical and have never been described before. We are therefore alert to the eventuality of false positive/negative PCR results targeting these genes with similar isolates. Use of WGS in clinical practice can help to solve such cases, even though time-to-result and costs should be considered.